Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Meares

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Cancer Research|April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in miceG P Adams, S J DeNardo, S V Deshpande, et al.
Cancer Research|February 15, 1995
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugatesD L Kukis, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1990
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agentS V Deshpande, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1978
Indium-111-labeled autologous platelets for location of vascular thrombi in humansD A Goodwin, J T Bushberg, P W Doherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976
Covalent attachment of metal chelates to proteins:the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indiumC F Meares, D A Goodwin, C S Leung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored miceS V Deshpande, S J DeNardo, C F Meares, et al.
PCR Methods and Applications|August 1, 1993
Rapid PCR construction of a gene containing Lym-1 antibody variable regionsX B Shi, P H Gumerlock, A A Wellman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2000
Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphomaG L DeNardo, R T O'Donnell, S Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji)G L DeNardo, D L Kukis, S Shen, et al.
Hybridoma|June 17, 1998
New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumorX Feng, R H Pak, L A Kroger, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Cancer Research|April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in miceG P Adams, S J DeNardo, S V Deshpande, et al.
Cancer Research|February 15, 1995
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugatesD L Kukis, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1990
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agentS V Deshpande, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1978
Indium-111-labeled autologous platelets for location of vascular thrombi in humansD A Goodwin, J T Bushberg, P W Doherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976
Covalent attachment of metal chelates to proteins:the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indiumC F Meares, D A Goodwin, C S Leung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored miceS V Deshpande, S J DeNardo, C F Meares, et al.
PCR Methods and Applications|August 1, 1993
Rapid PCR construction of a gene containing Lym-1 antibody variable regionsX B Shi, P H Gumerlock, A A Wellman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2000
Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphomaG L DeNardo, R T O'Donnell, S Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji)G L DeNardo, D L Kukis, S Shen, et al.
Hybridoma|June 17, 1998
New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumorX Feng, R H Pak, L A Kroger, et al.
Pageof 15